Recently, Li (33) found that increased expression of GGT1 in triple negative breast cancer caused cisplatin resistance by affecting the hepatic leukemia factor (HLF), a process that may be closely linked to IL-6 levels in the immune microenvironment (33). Here, IL6 is linked to triple-negative breast carcinoma.